The recently released pinkeye treatment, Cooper's Piliguard, has been touted as a complete solution to the costly condition. But modelling has shown that the indiscriminate use of the vaccine could be more costly than the impacts of pinkeye on Australia's cattle herd. Instead a tactical application of the treatment is likely to produce the best results. The blanket use of a recently released pinkeye vaccine could cost farmers more than the condition itself. Pinkeye costs the Australian beef herd 23.2million dollar a year in lost productivity and welfare problems. But there is no research to support the effectiveness of the new vaccine on cattle in Australian conditions and at $3.50 per head to apply, farmers could be treating some animals unnecessarily.
展开▼
